No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 4.8x · 10Y median 9.3x · 6th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 22
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:06:31.445Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T14:06:31.445Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T14:06:31.445Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Evolv Technologies Holdings, Inc. (EVLV) stock was $4.60 as of Oct 6, 2026, 10:05 AM EDT, up 2.57% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -39.8% · 3-year avg +0.0%/yr · 5-year avg -4.9%/yr
Evolv Technologies Holdings, Inc. develops, manufactures, markets, and sells security screening products and specific services in the United States and internationally.
Security & Protection Services · Waltham, MA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 10, 2026
35 days away
EPS Estimate
-0.06
Revenue Est.
$45.61M
Last Quarter Results
EPS
$-0.05
vs Estimate
$-0.03
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1EVLV | $826.51M | $4.59 | +2.57% | -39.80% | -4.87% | N/A | N/A |
| 2KRNT | $865.64M | $18.68 | +2.47% | +33.56% | -33.89% | +6.67% | vs EVLV |
| 3AEBI | $873.49M | $11.27 | +1.17% | -9.37% | N/A | N/A | vs EVLV |
| 4LYTS | $779.40M | $21.23 | +1.87% | -8.94% | +22.48% | +9.67% | vs EVLV |
| 5BBSI | $768.47M | $31.29 | +0.19% | -29.60% | +10.71% | +11.18% | vs EVLV |
| 6HTLD | $888.92M | $11.47 | -1.70% | +34.46% | -5.79% | -4.11% | vs EVLV |
forward FY estimate
N/A
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$43.75M
vs Estimate
$41.80M
Consensus Rating
Based on 5 analysts
Average Price Target
$9.85
+114.4% upside
Low
$8.00
Current
$4.59
High
$11.25
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.03 | $-0.03 | $-0.03 | 2 |
| Quarter ending Dec 2026 | $-0.02 | $-0.02 | $-0.02 | 2 |
| Quarter ending Mar 2027 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Quarter ending Jun 2027 | $-0.02 | $-0.02 | $-0.02 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.10 | $-0.10 | $-0.10 | 2 |
| FY 2027 | $-0.07 | $-0.07 | $-0.07 | 2 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $43.98M | $45.61M | $47.23M | 3 |
| Quarter ending Dec 2026 | $45.89M | $46.72M | $47.54M | 3 |
| Quarter ending Mar 2027 | $49.18M | $50.12M | $51.05M | 1 |
| Quarter ending Jun 2027 | $52.28M | $53.28M | $54.28M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $181.57M | $182.40M | $183.21M | 4 |
| FY 2027 | $218.34M | $218.90M | $219.46M | 4 |
